Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2025-12-25 @ 3:21 AM
NCT ID:
NCT01886105
Eligibility Criteria:
Inclusion Criteria:
* Patients must be between 13 and 65 years of age, inclusive
* Must have unresectable primary tumor or metastases
* Must have measurable disease that is demonstrated by positive Tc-99m Bone Scan. Not all lesions must be positive on bone scan.
* Creatinine clearance \>70ml/min/1.73m2
* ANC \>500/mm3
* Platelets \>50,000/mm3
* Life expectancy \> 8 weeks
* Karnofsky performance status \>50%
* Stem cell product collected prior to the infusion of Samarium must be available, either by peripheral stem cell mobilization or bone marrow harvest prior to trial entry.
Exclusion Criteria:
* Patient may not be pregnant or breastfeeding.
* Patients who have received prior radiotherapy to all areas of current active disease are not eligible.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
10 Years
Maximum Age:
65 Years
Study:
NCT01886105
Study Brief:
Protocol Section:
NCT01886105